Literature DB >> 82601

The presence of F9 antigen on the surface of mouse embryonic cells until day 8 of embryogenesis.

M H Buc-Caron, H Condamine, F Jacob.   

Abstract

The fate of F9, a surface antigen common to embryonal carcinoma cells and cleavage embryos, as well as to male germ line cells has been studied in post-implantation mouse embryos. The antigen is readily detected on the surface of 7-day and 8-day, but not on 9-day embryonic cells, using anti-F9 serum absorption experiments and indirect immunofluorescence staining. In addition, it is shown that an anti-F9 serum absorbed with 8-day (but not with 9-day) embryonic cells does not react with cleavage embryos (morulae). It is concluded that the antigenic determinants, which are recognized on the surface of morulae by the anti-F9 serum, persist until day 8 of embryogenesis, but are not detected on day 9, either due to their absence, masking or quantitative reduction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82601

Source DB:  PubMed          Journal:  J Embryol Exp Morphol        ISSN: 0022-0752


  9 in total

1.  A transcriptional enhancer and an interferon-responsive sequence in major histocompatibility complex class I genes.

Authors:  J Vogel; M Kress; G Khoury; G Jay
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

2.  Molecular analysis of the bare lymphocyte syndrome.

Authors:  K E Sullivan; J D Stobo; B M Peterlin
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Functional analysis of the mouse H-2Kb gene promoter in embryonal carcinoma cells.

Authors:  F Daniel-Vedele; A Israel; C Benicourt; P Kourilsky
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.

Authors:  K Ozato; Y J Wan; B M Orrison
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Asynchronous regulation of mouse H-2D and beta-2 microglobulin RNA transcripts.

Authors:  D Morello; P Duprey; A Israel; C Babinet
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.

Authors:  O Yano; J Kanellopoulos; M Kieran; O Le Bail; A Israël; P Kourilsky
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

7.  Serological identification and cellular distribution of three F9 antigen components.

Authors:  D Morello; H Condamine; C Delarbre; C Babinet; G Gachelin
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Structure and expression of the mouse beta 2-microglobulin gene isolated from somatic and non-expressing teratocarcinoma cells.

Authors:  F Daniel; D Morello; O Le Bail; P Chambon; Y Cayre; P Kourilsky
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.

Authors:  P Baldacci; C Transy; M Cochet; C Penit; A Israel; P Kourilsky
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.